Acute interstitial nephritis due to mesalazine

被引:21
作者
Tadic, M [1 ]
Grgurevic, I
Scukanec-Spoljar, M
Bozic, B
Marusic, S
Horvatic, I
Galesic, K
机构
[1] Univ Zagreb, Dubrava Univ Hosp, Dept Internal Med, Zagreb, Croatia
[2] Univ Zagreb, Zagreb Med Sch, Dept Pathol, Zagreb, Croatia
关键词
glomerulonephritis; inflammatory bowel disease; interstitial nephritis; mesalazine; monitoring renal function;
D O I
10.1111/j.1440-1797.2005.00376.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A case of mesalazine-induced acute interstitial nephritis (AIN) in a 41-year-old patient with ulcerative colitis (UC) is reported here. Clinical symptoms such as fever and arthralgia, and laboratory findings such as eosinophilia and renal failure suggested AIN, which was confirmed by biopsy. With withdrawal of mesalazine and intravenous methylprednisolone the patient's renal function was recovered. It is observed that early discontinuation of mesalazine is associated with amelioration of interstitial nephritis in most patients, so the recommendation is that patients receiving mesalazine should undergo routine monitoring of renal function. Delayed diagnosis may lead to permanent renal function impairment.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 13 条
[1]   Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis [J].
Birketvedt, GS ;
Berg, KJ ;
Fausa, O ;
Florholmen, J .
INFLAMMATORY BOWEL DISEASES, 2000, 6 (04) :275-279
[2]  
Calviño J, 1998, CLIN NEPHROL, V49, P265
[3]  
Dhiman R K, 1998, Indian J Gastroenterol, V17, P62
[4]   Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease [J].
Frandsen, NE ;
Saugmann, S ;
Marcussen, N .
NEPHRON, 2002, 92 (01) :200-202
[5]   Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy [J].
Fraser, JS ;
Muller, AF ;
Smith, DJ ;
Newman, DJ ;
Lamb, EJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (08) :1131-1137
[6]   MICROALBUMINURIA IN INFLAMMATORY BOWEL-DISEASE [J].
MAHMUD, N ;
STINSON, J ;
OCONNELL, MA ;
MANTLE, TJ ;
KEELING, PWN ;
FEELY, J ;
WEIR, DG ;
KELLEHER, D .
GUT, 1994, 35 (11) :1599-1604
[7]  
MOAYYEDI P, 1995, NEPHROL DIAL TRANSPL, V10, P1923
[8]   Late onset interstitial nephritis associated with mesalazine treatment [J].
Popoola, J ;
Muller, AF ;
Pollock, L ;
O'Donnell, P ;
Carmichael, P ;
Stevens, P .
BRITISH MEDICAL JOURNAL, 1998, 317 (7161) :795-797
[9]   Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines [J].
Ransford, RAJ ;
Langman, MJS .
GUT, 2002, 51 (04) :536-539
[10]   The influence of medications on the correlation between the Crohn's disease Activity Index and Inflammatory Bowel Disease Questionnaire in patients with Crohn's disease [J].
Su, CY ;
Lewis, JD ;
Lichtenstein, GR .
GASTROENTEROLOGY, 2003, 124 (04) :A197-A197